Miocene postcollisional potassic and adakitic rocks are widely distributed in the southern Lhasa terrane and western central Lhasa terrane. However, coeval potassic and adakitic rocks in eastern central Lhasa terrane were rarely recognized, and their origins and formation mechanism remain controversial. In this paper, we provide new geochronological and geochemical data for the Miocene postcollisional potassic and adakitic intrusions exposed in the Qingdu area, eastern central Lhasa terrane, southern Tibet. The Qingdu Miocene intrusions consist of quartz monzonite porphyry and biotite granite with coeval zircon U–Pb ages of 14.1 Ma and 14.0 Ma, respectively. They have high SiO2 (67.98–75.32 wt.%), Al2O3 (14.13–14.78 wt.%), and K2O (4.06–6.18 wt.%) and low MgO (0.25–1.46 wt.%) contents. They are both enriched in light rare earth elements (LREEs) and depleted in heavy rare earth elements (HREEs), with high (La/Yb)N (25.37–42.32) ratios. The biotite granite samples have low Y (7.10–9.96 ppm) and Yb (0.61–0.85 ppm) contents, and high Sr (229–384 ppm) contents and high Sr/Y (30–41) ratios, which show adakitic geochemical characteristics, whereas the quartz monzonite porphyry samples show potassic geochemical characteristics. They display initial (87Sr/86Sr)i ratios of 0.7083–0.7103, εHf(t) values of −6.7 to −0.1, εNd(t) values of −8.96 to −7.44, (208Pb/204Pb)i ratios of 39.028–39.110, (207Pb/204Pb)i ratios of 15.662–15.684, and (206Pb/204Pb)i ratios of 18.541–18.577. These signatures indicate that both the potassic and adakitic intrusions are more likely to originate from partial melting of a thickened lower crust, which were mainly the products of the binary mixing between the juvenile and ancient crust components. Based on the spatial distributions and isotopic features of the postcollisional potassic and adakitic rocks in the Lhasa terrane, we suggest that the differences of the lower crustal composition played a crucial role in causing the geochemical variations of the Miocene postcollisional adakitic and potassic rocks in Lhasa terrane.
A special elasto-plastic dynamic finite element code named RingForm has been developed
to analyze cold ring rolling process. Central difference method was introduced to solve the dynamic
explicit finite element equations. Strain state was estimated by the value of yield function of the last
and the present time step. To reduce the accumulative error caused by elasto-plastic constitutive
relations, the radial return algorithm was employed. In comparison with the experimental results, the
cold ring rolling process of a ring with rectangular section has been simulated to verify the accuracy
and stability of the system solver.
Plasma dipeptidyl-peptidase-4 activity (DPP4a) is inversely associated with left ventricular function in patients with heart failure (HF) or diabetes. However, the association between DPP4a and left ventricular function in ST-segment elevation myocardial infarction (STEMI) patients has not been reported. We studied this association in 584 consecutive STEMI patients at a tertiary referral center from July 2014 to October 2015. DPP4a and plasma N-terminal prohormone of B-type natriuretic peptide (NT-proBNP) levels were quantified by enzymatic assays. The median serum NT-proBNP levels were highest in patients of the lowest tertile (T1) of DPP4a compared with that of the highest tertile (T3) (p = 0.028). The STEMI patients in T1 exhibited lower left ventricular systolic function (T1 vs. T3: left ventricular ejection fraction (LVEF): 50.13 ± 9.12 vs. 52.85 ± 6.82%, p = 0.001). Multivariate logisticregression analyses (adjusted for confounding variables) showed that a 1 U/L increase in DPP4a was associated with a decreased incidence of left ventricular systolic dysfunction (LVSD) (adjusted odds ratio: 0.90; 95% CI: 0.87-0.94; p < 0.01). In conclusion, low DPP4a is independently associated with LVSD in STEMI patients, which suggests that DPP4 may be involved in the mechanisms of LVSD in STEMI patients.Left ventricular systolic dysfunction (LVSD), whose representative indicator is left ventricular ejection fraction (LVEF), is an important marker of poorer prognosis in patients after an acute myocardial infarction (AMI), for both in-hospital and long-term follow-up 1, 2 . Plasma biomarkers may provide insight into the pathogenesis of LVSD while also providing prognostic information in MI patients.Dipeptidyl-peptidase-4 (DPP4) is a widely expressed enzyme, cleaving off proteins containing a position 2 alanine or proline, and thus inactivating peptides 3 . DPP4 plays an important role in glucose metabolism and is responsible for the degradation of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide. DPP4 regulates immune responses via cleavage of many cytokines and chemokines, such as stromal-cell-derived factor-1 (SDF-1) 4 . Inhibition of DPP4 enhances endothelial regeneration and reduces atherosclerotic progression via the SDF1/chemokine receptor (CXCR)-4 axis 5 . Soluble DPP4 circulating in the plasma exerts catalytic activity cleaving oxyntomodulin 6 and SDF-1 7 , as does membrane-type DPP4. Soluble DPP4 plays a role in the development of insulin resistance, smooth muscle cell (SMC) proliferation, inflammation, and vasorelaxation 8 . Increased soluble DPP4 levels are associated with coronary artery disease 9 and heart failure (HF) 10 . We found that plasma DPP4 activity (DPP4a) is decreased in patients with MI compared with those with only chest pain or unstable angina pectoris. Also, we found that elevated DPP4a is associated with no-reflow phenomenon and a decreased rate of major bleeding events in ST-segment elevation myocardial infarction (STEMI) patients treated with percutaneous coronary ...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.